As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. Across the industry, companies are further continuing clinical research to assess whether modifications or boosters are warranted to existing vaccines to address emerging variants.